Literature DB >> 19454688

In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli.

Antonio Gigliotti Rothfuchs1, Jackson G Egen, Carl G Feng, Lis R V Antonelli, Andre Bafica, Nathalie Winter, Richard M Locksley, Alan Sher.   

Abstract

Although IL-12/23p40 is known to play a major role in host resistance to Mycobacterium spp, the cellular source, tissue localization, and regulation of p40 production during mycobacterial infection in vivo has been unclear. In this study, we used IL-12/23p40eYFP (yet40) reporter mice to track expression of the cytokine following Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection. We found that in spleens of these mice, p40 production is initiated by a transient burst from CD11b(low)CD11c(+) dendritic cells (DC) which are later replaced at the onset of granuloma formation by CD11b(high)CD11c(+) DC as the major source of the cytokine. The latter subset was also found to be the key producer of DC-derived p40 in nonlymphoid tissue and in both spleen and liver optimal production of the cytokine was regulated by endogenous TNF-alpha. Although BCG and p40-expressing DC were both observed in splenic white pulp, p40(+) DC rarely colocalized with bacilli. Indeed, in vitro flow cytometry and confocal microscopy indicated that the presence of intracellular bacteria is not required for p40 production by DC and Transwell experiments confirmed that soluble mycobacterial components are sufficient for inducing cytokine expression by these cells. Moreover, when stimulated with LPS, DC directly infected with BCG showed impaired IL-12p40 production in vitro. Together, our findings establish CD11b(high) DC as a major source of IL-12/23p40 during mycobacterial infection in situ and implicate both soluble mycobacterial products and TNF-alpha in stimulating sustained production of p40 by these cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454688      PMCID: PMC2786988          DOI: 10.4049/jimmunol.0900074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes.

Authors:  Valérie Abadie; Edgar Badell; Patrice Douillard; Danielle Ensergueix; Pieter J M Leenen; Myriam Tanguy; Laurence Fiette; Sem Saeland; Brigitte Gicquel; Nathalie Winter
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

Review 2.  Structure and function of the spleen.

Authors:  Reina E Mebius; Georg Kraal
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

3.  IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.

Authors:  Shabaana A Khader; John E Pearl; Kaori Sakamoto; Leigh Gilmartin; Guy K Bell; Dawn M Jelley-Gibbs; Nico Ghilardi; Fred deSauvage; Andrea M Cooper
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

4.  Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production.

Authors:  Carl G Feng; Dragana Jankovic; Marika Kullberg; Allen Cheever; Charles A Scanga; Sara Hieny; Patricia Caspar; George S Yap; Alan Sher
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

5.  Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages.

Authors:  Sushil Kumar Pathak; Sanchita Basu; Asima Bhattacharyya; Shresh Pathak; Manikuntala Kundu; Joyoti Basu
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

6.  Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin.

Authors:  M A O'Donnell; Y Luo; X Chen; A Szilvasi; S E Hunter; S K Clinton
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

7.  Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation.

Authors:  L Thompson-Snipes; E Skamene; D Radzioch
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

9.  In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas.

Authors:  C Reis e Sousa; S Hieny; T Scharton-Kersten; D Jankovic; H Charest; R N Germain; A Sher
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

10.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  17 in total

Review 1.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

2.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

Review 3.  Beyond macrophages: the diversity of mononuclear cells in tuberculosis.

Authors:  Smita Srivastava; Joel D Ernst; Ludovic Desvignes
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

4.  Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming.

Authors:  Smita Srivastava; Joel D Ernst
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

5.  TLR-2 independent recognition of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old mice.

Authors:  Erin K Rottinghaus; Bridget Vesosky; Joanne Turner
Journal:  Mech Ageing Dev       Date:  2010-06-08       Impact factor: 5.432

6.  Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes.

Authors:  Michael Y Gerner; Wolfgang Kastenmuller; Ina Ifrim; Juraj Kabat; Ronald N Germain
Journal:  Immunity       Date:  2012-08-02       Impact factor: 31.745

7.  Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut.

Authors:  Katja Obieglo; Xiaogang Feng; Vishnu Priya Bollampalli; Isabel Dellacasa-Lindberg; Cajsa Classon; Markus Österblad; Helena Helmby; James P Hewitson; Rick M Maizels; Antonio Gigliotti Rothfuchs; Susanne Nylén
Journal:  J Immunol       Date:  2016-01-27       Impact factor: 5.422

8.  BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAMlow CD11bhigh Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell Priming.

Authors:  Vishnu Priya Bollampalli; Lívia Harumi Yamashiro; Xiaogang Feng; Damiën Bierschenk; Yu Gao; Hans Blom; Birgitta Henriques-Normark; Susanne Nylén; Antonio Gigliotti Rothfuchs
Journal:  PLoS Pathog       Date:  2015-10-06       Impact factor: 6.823

9.  The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.

Authors:  Vijaya Satchidanandam; Naveen Kumar; Rajiv S Jumani; Vijay Challu; Shobha Elangovan; Naseem A Khan
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

10.  Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.

Authors:  Canan Ulusoy; Noushin Zibandeh; Selin Yıldırım; Nikolaos Trakas; Paraskevi Zisimopoulou; Melike Küçükerden; Hatice Tașlı; Socrates Tzartos; Kamil Göker; Erdem Tüzün; Tunç Akkoç
Journal:  J Neuroinflammation       Date:  2015-12-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.